Novel heterocyclic compound, carcinostatic agent, and carcinoma

Details Novel heterocyclic compound, carcinostatic agent, and carcinoma Novel heterocyclic compound, carcinostatic agent, and carcinoma

1990-05-25

1992-03-03

Page, Thurman K.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

549418, C07D31500

Patent

active

050935054

ABSTRACT:
Heterocyclic compounds of the general formula: ##STR1## wherein R.sup.11 is a hydroxyl group or a lower alkoxy group, R.sup.12 is a lower alkoxy group, R.sup.13 is a saturated or unsaturated hydrocarbon group, X is an oxygen atom or a sulfur atom, and Y is an oxygen atom or --NH-- which may have a lower alkyl substituent, or salts thereof are novel and effective in controlling carcinoma.

REFERENCES:
patent: 4891361 (1990-01-01), Hatae
Nishino et al, J. Kyoto Pref. Univ. Med. 96(3), 279-282, 1987.
Chem. Pharm. Bull., vol. 37, No. 6, Jun. 1989, Kodera et al., pp. 1656-1658.
The Merck Index, Ninth Edition, p. 5168.
Cancer Research, vol. 43, Sep. 1983, pp. 4216-4220, Ishida et al.
Stedman's Medical Dictionary, "carcinostatic" entry.
Allixin, A Stress Compound from Garlic Chem. Absts. 112, 1990, #73738n, Yukihivo et al.

Affiliated with

Also associated with

Rating

Novel heterocyclic compound, carcinostatic agent, and carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel heterocyclic compound, carcinostatic agent, and carcinoma , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel heterocyclic compound, carcinostatic agent, and carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-273540